Allogene Therapeutics (ALLO)'s 30-day implied volatility (IV30) was 64.6% at the close on October 22, 2026, down from 74.9% the day before, against a 52-week range of 51.1% to 189.5%. Its 20-day historical volatility was 55.5%.
Data as of October 22, 2026.